Mikhail Olferiev

Title: Mikhail Olferiev: Innovator in Biomarkers for Systemic Lupus Erythematosus

Introduction

Mikhail Olferiev is a notable inventor based in Mount Kisco, NY (US). He has made significant contributions to the field of medical research, particularly in the area of systemic lupus erythematosus (SLE). His work focuses on developing methods and assays that enhance the understanding and treatment of this complex autoimmune disease.

Latest Patents

Mikhail Olferiev holds a patent for "Biomarkers for disease activity and clinical manifestations systemic lupus erythematosus." This invention relates to innovative methods and assays for screening, identifying, and predicting the severity and clinical manifestations of SLE. The patent provides various biomarkers that can predict disease flares in both number and severity. It also offers methods for subclassifying patients with SLE, allowing for more tailored treatment approaches. Additionally, the invention includes biomarkers for lupus disease activity and future flare predictions, which are crucial for drug development and basic research in SLE.

Career Highlights

Mikhail Olferiev is affiliated with the New York Society for the Ruptured and Crippled Maintaining the Hospital for Special Surgery. His work at this institution has allowed him to collaborate with leading experts in the field and contribute to advancements in medical science.

Collaborations

Mikhail has worked alongside Mary K Crow, a fellow researcher, to further explore the implications of his findings in the medical community.

Conclusion

Mikhail Olferiev's innovative work in the field of biomarkers for systemic lupus erythematosus represents a significant advancement in understanding and treating this challenging disease. His contributions are poised to make a lasting impact on patient care and research in autoimmune disorders.